DE69623155T2 - Verfahren zur transdermalen Verabreichung von Medikamenten - Google Patents

Verfahren zur transdermalen Verabreichung von Medikamenten

Info

Publication number
DE69623155T2
DE69623155T2 DE69623155T DE69623155T DE69623155T2 DE 69623155 T2 DE69623155 T2 DE 69623155T2 DE 69623155 T DE69623155 T DE 69623155T DE 69623155 T DE69623155 T DE 69623155T DE 69623155 T2 DE69623155 T2 DE 69623155T2
Authority
DE
Germany
Prior art keywords
voltage
drug delivery
transdermal drug
calcitonin
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69623155T
Other languages
English (en)
Other versions
DE69623155D1 (de
Inventor
Katsumi Iga
Shigeo Yanai
Keiichiro Okabe
Masaki Itoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Advance Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc, Advance Co Ltd filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of DE69623155D1 publication Critical patent/DE69623155D1/de
Application granted granted Critical
Publication of DE69623155T2 publication Critical patent/DE69623155T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
DE69623155T 1995-03-17 1996-03-15 Verfahren zur transdermalen Verabreichung von Medikamenten Expired - Fee Related DE69623155T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8629095 1995-03-17

Publications (2)

Publication Number Publication Date
DE69623155D1 DE69623155D1 (de) 2002-10-02
DE69623155T2 true DE69623155T2 (de) 2003-04-17

Family

ID=13882714

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69623155T Expired - Fee Related DE69623155T2 (de) 1995-03-17 1996-03-15 Verfahren zur transdermalen Verabreichung von Medikamenten

Country Status (5)

Country Link
US (1) US5700481A (de)
EP (1) EP0732121B1 (de)
AT (1) ATE222789T1 (de)
CA (1) CA2171910A1 (de)
DE (1) DE69623155T2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5735810A (en) * 1996-06-14 1998-04-07 Becton Dickinson And Company Device for the iontophoretic administration of bisphosphonates
US6775569B2 (en) * 1997-11-05 2004-08-10 Hisamitsu Pharmaceutical Co., Inc. Electroporation device for in vivo delivery of therapeutic agents
CA2269050A1 (en) 1998-04-14 1999-10-14 Shigeo Yanai Method for transdermal administration of gp iib/iiia antagonist
US6406455B1 (en) 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
WO2000048669A1 (en) 1999-02-18 2000-08-24 Biovalve Technologies, Inc. Electroactive pore
US6591133B1 (en) 2000-11-27 2003-07-08 Microlin Llc Apparatus and methods for fluid delivery using electroactive needles and implantable electrochemical delivery devices
US6571125B2 (en) * 2001-02-12 2003-05-27 Medtronic, Inc. Drug delivery device
US7349733B2 (en) * 2001-11-02 2008-03-25 Ceramatel, Inc. Iontophoretic drug delivery systems
US7047069B2 (en) 2002-02-04 2006-05-16 Ceramatec, Inc. Iontophoretic fluid delivery device
US6775570B2 (en) 2002-02-04 2004-08-10 Ceramatec, Inc. Iontophoretic treatment device
CA2500713C (en) * 2002-10-04 2012-07-03 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
US20070025869A1 (en) * 2005-07-15 2007-02-01 Gordon John H Fluid Delivery Device
WO2007120747A2 (en) * 2006-04-13 2007-10-25 Nupathe Inc. Transdermal methods and systems for the delivery of anti-migraine compounds
US8214030B2 (en) * 2006-09-06 2012-07-03 Encore Medical Asset Corporation Iontophoresis apparatus and method
US20080147186A1 (en) * 2006-12-14 2008-06-19 Joshi Ashok V Electrochemical Implant For Delivering Beneficial Agents
US20080177219A1 (en) * 2007-01-23 2008-07-24 Joshi Ashok V Method for Iontophoretic Fluid Delivery
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
JP2585002B2 (ja) * 1987-07-02 1997-02-26 日東電工株式会社 経皮薬物投与用の電圧印加装置
JPS6411565A (en) * 1987-07-03 1989-01-17 Nitto Denko Corp Drug admistrating method by iontophoresis
JP2834157B2 (ja) * 1988-11-04 1998-12-09 久光製薬株式会社 イオントフォレーシス用デバイス
US5167616A (en) * 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
US5207752A (en) * 1990-03-30 1993-05-04 Alza Corporation Iontophoretic drug delivery system with two-stage delivery profile
USH1160H (en) * 1990-11-26 1993-04-06 Iontophoretic delivery of peptides
EP1138345A3 (de) * 1993-09-22 2003-06-04 Hisamitsu Pharmaceutical Co., Inc. Eine Matrix für die Iontophorese

Also Published As

Publication number Publication date
US5700481A (en) 1997-12-23
ATE222789T1 (de) 2002-09-15
EP0732121A1 (de) 1996-09-18
DE69623155D1 (de) 2002-10-02
CA2171910A1 (en) 1996-09-18
EP0732121B1 (de) 2002-08-28

Similar Documents

Publication Publication Date Title
DE69623155T2 (de) Verfahren zur transdermalen Verabreichung von Medikamenten
DE68910520D1 (de) Verfahren zur Verminderung von Hautirritationen bei Anwendung von durchdringungsverstärkenden Arzneimittelzusammensetzungen.
ATE165983T1 (de) Reduktion von hautirritationen und hautwiderstand während einer iontophoresebehandlung
DE69519393T2 (de) Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung
WO1991008795A3 (en) Improved iontophoretic delivery method
TW368420B (en) Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
DE69422354T2 (de) Vorrichtung mit drei Modulen zur iontophoretischen oder elektrophoretischen transdermalen Abgabe von Medikamenten
DE69114442T2 (de) Verfahren und Gerät zur Rhythmuskorrektur und Stimulation des Herzens in Abhängigkeit von Neurosignalen.
DE69535556D1 (de) Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe
DE69324680T2 (de) Elektrische stimulierung zur behandlung von inkontinenz und anderen neuromuskularerkrankungen
DE69623608T2 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
ATE514373T1 (de) Minimalinvasives system und verfahren zur überwachung von analytenkonzentrationen
ATE157016T1 (de) Behandlungssystem durch iontophorese
DE60121194D1 (de) System zur veränderung von therapieparametern
DE69103137D1 (de) Verfahren und vorrichtung zum anbringen von paste und klebemitteln.
DE69102783D1 (de) Reduzierende kosmetische Zusammensetzung zur Haardauerwellung auf Basis eines Esters der Thioglycolsäure und eines N-Acyl(C2-C4)-Cysteamines sowie Verfahren zu deren Anwendung.
ATE189417T1 (de) Verfahren zur abtötung von mikroorganismen und/oder mineralisierung organischer substanzen im boden und/oder im grundwasser
FI915878A0 (fi) Menetelmä ja laite elektrolyyttiliuoksen käsittelemiseksi sähköisesti
DE69532477D1 (de) Zusammensetzung, vorrichtung und verfahren zur verbesserten elektrotransport-wirkstoffabgabe
DE69423836D1 (de) Apparat zur Stimulierung von Nerven
DE69723995D1 (de) Vorrichtung zur iontophoretischen verabreichung von medikamenten mit verfahren zur aktivierung derselben
ATE373957T1 (de) Verfahren und vorrichtung zur transdermalen verabreichung von lithium
DE69613370T2 (de) Zusammensetzung und verfahren zur verstärkung von elektrotransport-wirkstoffzufuhr
DE69115687D1 (de) Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese
ATE20313T1 (de) Elektrotherapeutische vorrichtung.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: HISAMITSU PHARMACEUTICAL CO., INC., TOSU, SAGA, JP

8339 Ceased/non-payment of the annual fee